SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-391481
Filing Date
2013-10-04
Accepted
2013-10-04 15:06:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d607307dsc13d.htm SC 13D 63484
2 EX-1 d607307dex1.htm EX-1 18209
3 EX-2 d607307dex2.htm EX-2 364291
  Complete submission text file 0001193125-13-391481.txt   447577
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Subject) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87628 | Film No.: 131136526
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10A 60-LETIYA OKTYABRYA PROSPECT MOSCOW 1Z 117036
Business Address 10A 60-LETIYA OKTYABRYA PROSPECT MOSCOW 1Z 117036 495-988-5388
RUSNANO (Filed by) CIK: 0001548606 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 1Z
Type: SC 13D